Impact of diabetes on TB treatment outcomes and immune response

Location

Pune, India

Dates

02/01/2013 - 01/01/2018

PI

Jonathan Golub, PhD, MPH

This is a study to prospectively enroll and follow TB patients co-infected with diabetes and TB patients without diabetes to compare TB outcomes in India.

People

Eric Nuermberger, MD
Faculty
Kelly Dooley, MD, PhD
Faculty
Amita Gupta, MD, MHS
MentorCo-DirectorLeadershipFaculty
Jason Farley, PhD, MPH, CRNP, FAAN
Faculty
Emily Kendall, MD, PhD
Faculty

Projects

FlexDx-TB: A flexible, user-friendly model of...

We have developed a web-based model that allows decision-makers to input local epidemiological and economic values and receive...

Read More

Understanding the role of repeat testing and...

We have developed a Markov model of serial IGRA testing to help improve testing algorithms with TST vs. IGRA in low-risk...

Read More

A Nurse Case Management Intervention to...

Dr. Farley is responsible for the overall project from design, implementation, data collection, and preparation of...

Read More

Immunotherapy Targeting MTB Persisters in the...

The goal of this research program is to determine whether enhanced immunity to critical components of the Mtb stringent response...

Read More

TBM-KIDS (Malawi)

A phase 2 clinical trial of optimized treatment for pediatric tuberculous meningitis in India and Malawi

Read More